Tian Mao group prepared to raise more than 1 billion increase in chemical and pharmaceutical

Days Mao Group (000627) announced today the targeted additional plans. The proposed non-public offering does not exceed 240 million shares and the net amount of funds raised does not exceed 1.03 billion yuan. The funds are intended to be used for 300,000 tonnes/year C4 olefin cracking works, 50 tons/year prednisolone, 20 tons/year Methylprednisolone projects and 500 tons of naproxen.　　Three projects after the launch of the days of the group will add about 220 million yuan per year profit, greatly improve the profitability of the company.　　This increase to no more than 10 specific objects issued, the price is not less than February 28, 2011 (Pricing base date) The first 20 trading days of the company's stock Exchange 90%. In three projects, 300,000 tons/year C4 olefin cracking project total investment of 500 million yuan, is expected to achieve annual sales revenue of 1.85 billion yuan, the average annual increase in total profit of 91.95 million yuan.　　The project can relieve the tension of the company propylene raw material supply, meet the needs of the company's polypropylene production equipment, the formation of C4 olefin cracking and polypropylene industry chain, increase the company's ability to resist risk. The total investment of 50 tons/year prednisolone and 20 tons/year Methylprednisolone project is 420 million yuan.　　The average annual sales revenue is expected to achieve 570 million yuan, the average annual increase in total profit of 107 million yuan. Annual output of 500 tons of naproxen project total investment of 104 million yuan, is expected to achieve annual average sales revenue of 100 million yuan, the average annual increase in total profit of 17.9 million yuan. (threading)